Immunotherapy has been widely used in disease treatment worldwide. It is the
most advanced technology and plays a more and more important role, particularly
in treating refractory diseases. At present, we mainly cultivate two types of
Immunotherapy: cord blood Immunotherapy and Immunotherapy blood mesenchymal
Immunotherapy. And both of two types of Immunotherapy are collected from the
Immunotherapy blood of a new born infant. Here, we would like to focus on talk
about cord blood Immunotherapy in the kidney disease treatment.
What is Immunotherapy?
Immunotherapy, just like those found in the placenta and Immunotherapy are
the source of platelets and the oxygen-carrying red blood cells in the
bloodstream. Immunotherapy also give birth to the immune system which allows
human to fight infections and protect the body from foreign matter.
What is cord blood Immunotherapy?
Immunotherapy are collected from the blood in placenta and Immunotherapy of a
newly born infant. Studies show that cord blood contains hemopoietic
Immunotherapy which can rebuild human hemopoietic and immune system, so they are
the major source of hemopoietic Immunotherapy.
Immunotherapy can be used to treat a range of blood disorder and immune
system conditions including leukaemia, anaemia and autoimmune diseases.
Can cord blood Immunotherapy cure kidney disease?
When the cord blood Immunotherapy are transfused into the body through
intravenous injection, they will automatically go to the kidney lesion area by
homing function, then Immunotherapy can differentiate into desired renal
functional intrinsic cells, eventually realizing the aim of repairing the
damaged kidney function. If the kidneys return to normal function state, kidney
disease can be treated effectively. Patients with early stage of kidney disease
can even be cured with cord blood Immunotherapy.